Sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir: novel treatment options for na ïve and previously treated hepatitis C infection

Korean J Intern Med. 2023 Jul;38(4):454-455. doi: 10.3904/kjim.2023.248. Epub 2023 Jun 30.NO ABSTRACTPMID:37424499 | DOI:10.3904/kjim.2023.248

Source: The Korean Journal of Internal Medicine - July 10, 2023 Category: Internal Medicine Authors: Hyun Phil Shin Source Type: research